Global PARP Inhibitor Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Cancer and Rising Geriatric Population
The global PARP Inhibitor Market is estimated to be valued at USD 6.60 billion in 2022 and is expected to exhibit a CAGR of 13.09% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.A) Market Overview:PARP inhibitors are a class of drugs that inhibit the activity of Poly (ADP-ribose) polymerase (PARP) enzymes in the body. These enzymes play...
0 Commenti 0 condivisioni 2455 Views 0 Anteprima
Sponsorizzato